Amaranth Medical 9-Months Clinical and Imaging Results of the FORTITUDE Sirolimus-Eluting Bioresorbable Scaffold Presented at TCT
31 oct. 2016 12h30 HE
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA, Oct. 31, 2016 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, announced that a presentation of the 9-month clinical and imaging results from the...
Medstar Union Memorial Hospital Makes Pioneering Strides in Coronary Care
08 août 2016 17h53 HE
|
MedStar Health
BALTIMORE, MD--(Marketwired - August 08, 2016) - MedStar Union Memorial Hospital became the first and only hospital in Maryland to offer a fully dissolvable cardiac stent to patients fighting coronary...
Amaranth Medical Completes Enrollment in RENASCENT-II Study of 120-Micron APTITUDE™ Sirolimus-Eluting Bioresorbable Scaffold
06 juin 2016 08h00 HE
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA , June 06, 2016 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, announced that it completed enrollment in May 2016 in the RENASCENT-II study of its...
Amaranth Medical On Track to Complete Enrollment in RENASCENT-II Study of 120-Micron APTITUDE™ Sirolimus-Eluting Bioresorbable Scaffold in May
18 mai 2016 03h01 HE
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA , May 18, 2016 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, provided a clinical update on its ongoing RENASCENT-II study of its novel APTITUDE™...
Amaranth Medical Initiates Clinical Trial of the Second-Generation FORTITUDE Bioresorbable Drug-Eluting Scaffold
16 sept. 2014 09h00 HE
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA, Sept. 16, 2014 (GLOBE NEWSWIRE) -- Amaranth Medical, a
privately held medical device company, announced the initiation of
patient enrollment in multiple centers in Colombia, South...
Amaranth Medical Raises $20 Million in Series B to Support Development of the FORTITUDE(tm) Bioresorbable Scaffold
07 oct. 2013 20h00 HE
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA, Oct. 7, 2013 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company,
announced the closing of a $20 million Series B financing led by
new investor DCP...